SEC Form 4 · accession 0001104659-26-087584
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Joe Pitts
Officer — Executive Chairman · Director
Period of report
Jul 24, 2026
Accepted (ET)
Jul 28, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001137883
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $1.00 | Jul 24, 2026 | A | 900,000 | A | — | Jul 24, 2036 | Common Stock | 900,000 | 900,000 | D |
Explanation of responses
- F1Represents options to purchase common stock, granted under the Issuer's 2014 Stock Incentive Plan.
- F2The stock options vest over 48 months, with 25% vesting on July 24, 2027 and 1/48th vesting monthly thereafter, provided that the Reporting Person remains employed by the Issuer through each applicable vesting date.